A program to collect cancer-related samples and data for better cancer care
INST UNM 1521: Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
This study is collecting blood, tissue, and other samples from people with cancer or at risk of it to help improve cancer care and treatment in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 47500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | New Mexico Cancer Research Alliance Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Trial ID | NCT03977402 on ClinicalTrials.gov |
What this trial studies
This program aims to enhance cancer care by creating a comprehensive repository of biological samples and associated data from patients diagnosed with cancer or at risk of developing it. Participants will provide blood, tissue, and other biological samples, along with survey responses and medical records, to support ongoing cancer research and personalized medicine initiatives. The data collected will be utilized to facilitate new clinical trials and improve cancer treatment standards through collaboration with various healthcare providers. This is an observational study, meaning it does not involve any treatment interventions.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18 and older who have been diagnosed with cancer or are suspected of having cancer.
Not a fit: Patients who are prisoners will not be eligible to participate in this study.
Why it matters
Potential benefit: If successful, this initiative could lead to significant advancements in personalized cancer treatment and improved patient outcomes.
How similar studies have performed: Other studies have successfully established similar biorepositories, indicating a promising approach to enhancing cancer research and treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and older. * Has a diagnosis of cancer or is suspected of having cancer. * Able to understand and sign the Informed Consent form directly. * Pregnant women are permitted to be enrolled. Exclusion Criteria: * Prisoners
Where this trial is running
Albuquerque, New Mexico
- University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico, United States (Recruiting)
Study contacts
- Principal investigator: Leslie Andritsos, MD — University of New Mexico Cancer Center
- Study coordinator: Christine Serway, PhD
- Email: CSerway@salud.unm.edu
- Phone: 505-272-2412
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.